123 related articles for article (PubMed ID: 10319410)
21. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus.
Czar MJ; Galigniana MD; Silverstein AM; Pratt WB
Biochemistry; 1997 Jun; 36(25):7776-85. PubMed ID: 9201920
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
[TBL] [Abstract][Full Text] [Related]
23. Geldanamycin treatment during cerebral ischemia/reperfusion attenuates p44/42 mitogen-activated protein kinase activation and tissue damage.
Karabiyikoglu M; Hua Y; Keep RF; Xi G
Acta Neurochir Suppl; 2013; 118():39-43. PubMed ID: 23564101
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.
Stebbins CE; Russo AA; Schneider C; Rosen N; Hartl FU; Pavletich NP
Cell; 1997 Apr; 89(2):239-50. PubMed ID: 9108479
[TBL] [Abstract][Full Text] [Related]
25. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
Schulte TW; An WG; Neckers LM
Biochem Biophys Res Commun; 1997 Oct; 239(3):655-9. PubMed ID: 9367823
[TBL] [Abstract][Full Text] [Related]
26. Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts.
Wax S; Piecyk M; Maritim B; Anderson P
Arthritis Rheum; 2003 Feb; 48(2):541-50. PubMed ID: 12571865
[TBL] [Abstract][Full Text] [Related]
27. Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells.
Vasilevskaya IA; O'Dwyer PJ
Cancer Res; 1999 Aug; 59(16):3935-40. PubMed ID: 10463587
[TBL] [Abstract][Full Text] [Related]
28. Different early effets of tyrphostin AG957 and geldanamycins on mitogen-activated protein kinase and p120cbl phosphorylation in anti CD-3-stimulated T-lymphoblasts.
Losiewicz MD; Kaur G; Sausville EA
Biochem Pharmacol; 1999 Feb; 57(3):281-9. PubMed ID: 9890555
[TBL] [Abstract][Full Text] [Related]
29. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association.
Schulte TW; Blagosklonny MV; Ingui C; Neckers L
J Biol Chem; 1995 Oct; 270(41):24585-8. PubMed ID: 7592678
[TBL] [Abstract][Full Text] [Related]
30. The Ah receptor is a sensitive target of geldanamycin-induced protein turnover.
Chen HS; Singh SS; Perdew GH
Arch Biochem Biophys; 1997 Dec; 348(1):190-8. PubMed ID: 9390191
[TBL] [Abstract][Full Text] [Related]
31. Requirement of heat shock protein 90 in mesangial cell mitogenesis.
Pieper M; Rupprecht HD; Bruch KM; De Heer E; Schöcklmann HO
Kidney Int; 2000 Dec; 58(6):2377-89. PubMed ID: 11115071
[TBL] [Abstract][Full Text] [Related]
32. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
[TBL] [Abstract][Full Text] [Related]
33. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
34. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
Marcu MG; Schulte TW; Neckers L
J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441
[TBL] [Abstract][Full Text] [Related]
35. Depletion of Raf-1 protooncogene by geldanamycin causes apoptosis in human luteinized granulosa cells.
Khan SM; Oliver RH; Dauffenbach LM; Yeh J
Fertil Steril; 2000 Aug; 74(2):359-65. PubMed ID: 10927059
[TBL] [Abstract][Full Text] [Related]
36. Role of the heat shock protein 90 in immune response stimulation by bacterial DNA and synthetic oligonucleotides.
Zhu FG; Pisetsky DS
Infect Immun; 2001 Sep; 69(9):5546-52. PubMed ID: 11500428
[TBL] [Abstract][Full Text] [Related]
37. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
[TBL] [Abstract][Full Text] [Related]
38. Altered states: selectively drugging the Hsp90 cancer chaperone.
Workman P
Trends Mol Med; 2004 Feb; 10(2):47-51. PubMed ID: 15106614
[TBL] [Abstract][Full Text] [Related]
39. [Molecular chaperone HSP90 as a novel target for cancer chemotherapy].
Miyata Y
Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):33-42. PubMed ID: 12617036
[TBL] [Abstract][Full Text] [Related]
40. Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest.
Bedin M; Gaben AM; Saucier C; Mester J
Int J Cancer; 2004 May; 109(5):643-52. PubMed ID: 14999769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
